[1]尤金枝,王捷虹,高麦仓△,等.尿激酶、低分子肝素对脓毒症弥散性血管内凝血大鼠模型的影响研究*[J].陕西医学杂志,2020,49(9):1071-1073,1077.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.004]
　YOU Jinzhi,WANG Jiehong,GAO Maicang,et al.Study of urokinase and low molecular weight heparin on sepsis DIC rats model[J].,2020,49(9):1071-1073,1077.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.004]
点击复制

尿激酶、低分子肝素对脓毒症弥散性血管内凝血大鼠模型的影响研究*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年9期
页码:
1071-1073,1077
栏目:
基础研究
出版日期:
2020-09-01

文章信息/Info

Title:
Study of urokinase and low molecular weight heparin on sepsis DIC rats model
作者:
尤金枝; 王捷虹; 高麦仓△; 王瑞哲; 任耀龙; 王晨曦; 王 博; 梁嘉斌; 刘 旺; 于 勇
陕西中医药大学附属医院(咸阳712000)
Author(s):
YOU Jinzhi; WANG Jiehong; GAO Maicang; et al.
The Affiliated Hospital of Shaanxi University of Chinese Medicine(Xianyang 712000)
关键词:
尿激酶;  低分子肝素;  脓毒症;  弥散性血管内凝血
Keywords:
Urokinase;  Low molecular weight heparin;  Sepsis;  Disseminated intravascular coagulation
分类号:
R554
DOI:
DOI:10.3969/j.issn.1000-7377.2020.09.004
文献标志码:
A
摘要:
目的:考察尿激酶(UK)、低分子肝素(LMWH)对脓毒症弥散性血管内凝血(DIC)大鼠模型的影响,比较两者在治疗脓毒症致DIC中的差异,为规范应用两药治疗脓毒症DIC提供实验支撑和理论依据。方法:建立脓毒症DIC大鼠模型,检测凝血指标和纤溶指标,分析其对大鼠凝血功能、微循环、纤溶活性的作用。结果:输注脂多糖(LPS)后引起模型组大鼠凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)延长,纤维蛋白原(FBG)、血小板(PLT)下降,D-二聚体(DD)升高,经UK、LMWH干预后PT、APTT缩短,FBG、PLT升高,DD下降,与LPS组比较,差异具有统计学意义(P<0.05)。结论:尿激酶和低分子肝素均可防治脓毒症DIC,后者较前者更安全。
Abstract:
Objective:To investigate the effects of urokinase(UK)and low molecular weight heparin(LMWH)on sepsis DIC rats model,to compare the therapeutic effect between them in the treatment of DIC caused by sepsis,to provide experimental support and theoretical basis for the standardized application of the drug in the treatment of sepsis DIC.Methods:The sepsis DIC rats model was established,the coagulation index and fibrinolytic index were detected,and the effects on coagulation function,microcirculation and fibrinolysis activity were analyzed.Results:After LPS infusion,PT and APTT were prolonged,FBG and PLT were decreased,DD was increased in model group.After UK/LMWH intervention,PT and APTT were shortened,FBG and PLT were increased,DD was decreased.Compared with LPS group,the difference was statistically significant(P<0.05).Conclusion:Both UK and LMWH can prevent and treat sepsis DIC.LMWH is safer than UK.

参考文献/References:

[1] Singer M,Deutschmanc CS,Seymourc CW,et al.The third international consensus definitions for sepsis and septic shock(sepsis-3)[J].JAMA,2016,315(8):801-810.
[2] 曹佳杨,华 英,何 艺,等.姜黄素通过激活SIRT1调节脓毒症小鼠模型的认知功能障碍研究[J].陕西中医,2020,41(3):301-307.
[3] 张二飞,李 楠,赵晓英,等.脓毒症后认知功能障碍的研究进展[J].中华全科医学,2017,15(4):667-671.
[4] 田永超.脓毒症肠黏膜屏障功能障碍防治研究进展[J].陕西医学杂志,2020,49(4):510-513.
[5] 戴晓勇,陈永珍,叶宥文,等.不同营养支持方式对血流动力学不稳定脓毒性休克患者T淋巴细胞亚群及疾病预后的影响[J].陕西医学杂志,2020,49(2):183-186.
[6] 陈 琛,苏 华,蒋丽娜,等.TNF-α和IL-10与重症脓毒症患者预后的相关性研究[J].陕西医学杂志,2016,45(12):1600-1601.
[7] Perner A,Cecconi M,Cronhjort M,et al.Expert statement for the management of hypovolemiain sepsis[J].Intensive Care Med,2018,44(6):791-798.
[8] Prescott HC,Angus DC.Post sepsis morbidity[J].JAMA,2018,319(1):91.
[9] 王东强,田永超,李志军.脓毒症诊断的生物学标志物[J].陕西医学杂志,2011,40(3):361-364.
[10] 文柯力,陈雪梅.脓毒症合并弥散性血管内凝血的机制及抗凝治疗研究进展[J].现代医药卫生,2019,35(9):1370-1374.
[11] Didier P.Sepsis:choc septique réfractaire et coagulation[J].Anesthésie & Réanimation,2019,5(4):1084-1091.
[12] 宋景春.脓毒症合并弥散性血管内凝血的机制与监测[J].医学研究生学报,2017,30(7):703-708.
[13] 文柯力.脓毒症合并弥散性血管内凝血的机制及抗凝治疗进展[D].重庆:重庆医科大学,2019.
[14] 刘 琴.脓毒症早期应用低分子肝素预防弥散性血管内凝血的研究[J].中国社区医师,2017,33(32):61-62,64.
[15] 袁凯锋,廖小梅,于 磊,等.内毒素诱导Wistar大鼠DIC模型建立及尿激酶干预作用的研究[J].四川大学学报:医学版,2010,41(6):965-969.
[16] Di Nisio M,Baudo F,Cosmi B,et al.Diagnosis and treatment of disseminated intravascular coagulation:guidelines of the Italian Society for Haemostasis and Thrombosis(SISET)[J].Thrombosis Research,2012,129(5):e177-184.
[17] 段圣洁,徐梦霞.低分子肝素应用于治疗新生儿脓毒症并弥散性血管内凝血患儿的临床观察[J].首都食品与医药,2019,26(21):77-78.
[18] 尤金枝,王捷虹,郑 刚,等.低分子肝素钙治疗脓毒症胃肠功能障碍患者的临床效果[J].临床医学研究与实践,2020,5(6):12-13.
[19] 宋晓敏,吴 阳,曾俊杰.不同剂量尿激酶对脓毒症性凝血紊乱大鼠干预作用的实验研究[J].中国医药,2019,14(10):1539-1542.

相似文献/References:

[1]张 晨,宋国瑞,刘子歌,等.低分子肝素与利伐沙班预防全膝关节置换术后静脉血栓成形的疗效及安全性对比分析*[J].陕西医学杂志,2020,49(9):1153.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.025]
　ZHANG Chen,SONG Guorui,LIU Zige,et al.Comparative analysis of the efficacy and safety of low molecular weight heparin and rivaroxaban in prevention of venous thrombosis after TKA[J].,2020,49(9):1153.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.025]
[2]李 欢,张 坤.不同黄体酮给药方式联合低分子肝素对不明原因复发性流产患者再次妊娠的影响对比研究[J].陕西医学杂志,2024,(8):1101.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.021]
　LI Huan,ZHANG Kun.Comparison of the effects of different progesterone administration methods combined with low molecular weight heparin on re-pregnancy in patients with unexplained recurrent spontaneous abortion[J].,2024,(9):1101.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.021]

备注/Memo

备注/Memo:
*陕西省自然科学基础研究计划项目(2018JM7122);陕西省中医药管理局中医药科研课题(15-LC006);陕西省咸阳市科学技术研究计划项目(2017K02-87,2017K02-88);陕西中医药大学科研基金资助项目(2015QN32)
更新日期/Last Update: 2020-09-02